UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Explore practical ways to minimize the financial impact of budgeting mistakes and implement safeguards to protect money and goals.
22,127 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
As Magnachip heads into 2025 earnings season, investors want clarity on revenue growth, margins, and capital allocati...
A high-profile insider sale can shake investor nerves. This guide explains what the Dropbox stock sell after event mi...
Mission Produce enters 2026 with a mix of hedges, growing demand, and a tight supply chain. This guide breaks down wh...
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Investor nerves rose as here's gemini space station faced a sharp price drop this week. This piece breaks down what s...
When a chief financial officer sells a sizable chunk of stock, it draws attention. This article breaks down the impli...
Cloudflare's first-quarter 2026 results set the stage for a dynamic year. This analysis breaks down what worked, what...
A single, sizable move out of a momentum ETF can reveal where market leadership is shifting. This article explains wh...
ClearPoint’s early-2026 earnings signal a busy year ahead. This analysis breaks down revenue, margins, guidance, and ...
Bitcoin plunged to multi-week lows as traders priced in renewed tensions between the U.S. and Iran, triggering massiv...